Psychedelic tourism growth in Europe: EMCDDA trend data
What EMCDDA and EU drug-monitoring trends can and cannot say about psychedelic tourism growth in Europe.
Read article →
AI and psychedelic research: simulation, screening, and hype boundaries
AI in psychedelic research: useful screening and logistics versus simulation hype, data scarcity, and regulator expectations in 2026.
Read article →
Psychedelic patents and open science tensions
How psychedelic IP filings clash with open science: prior art projects, USPTO and WIPO pathways, synthesis controversies, and why Dutch sclerotia programmes are not patent medicines.
Read article →
Psychedelic biotech companies in 2026: who is researching what
A 2026 map of psychedelic biotech pipelines: who studies psilocybin, MDMA, DMT, and related compounds, how trials differ from retreat markets, and how to read company claims without hype.
Read article →
EU drug agency reports on psilocybin prevalence and harm
EU Drugs Agency reports calibrate psilocybin prevalence and harm without granting retail rights. Learn how to read the tables without slogan science.
Read article →
OECD and WHO perspectives on psychedelic policy harmonization
OECD and WHO shape evidence and governance languages for psychedelic policy. Harmonization can mean shared safety standards, not a world retail switch.
Read article →
Mexico psilocybin mushroom traditions and modern enforcement
Mexico holds living mushroom traditions and modern narcotics enforcement at once. Tourism slogans do not repeal either system.
Read article →
Brazil and ayahuasca vs psilocybin legal contrasts
Brazil's ayahuasca religious recognition does not automatically cover psilocybin. Substance-specific legal contrasts protect travelers and communities from false assumptions.
Read article →
Australia rescheduling psilocybin for therapy: what changed
Australia's rescheduling enabled authorized specialist prescribing under tight conditions. Here is what changed, what did not, and how to avoid tourism myths.
Read article →
Canada psilocybin exemptions and Special Access Program
Canada's exemptions and Special Access Program are real clinical tools, not retail legalization. Learn what they authorize, refuse, and how patients can verify claims.
Read article →
Belgium and truffle tourism: cross border legal notes
Belgium sits beside Dutch sclerotia retail culture, which fuels truffle-tourism myths. Cross-border legal notes explain why Schengen convenience is not a Benelux free-for-all.
Read article →
France and psychedelic research: current academic landscape
France keeps psilocybin tightly controlled while universities and hospitals slowly rebuild psychedelic research capacity. Here is how to read the academic landscape without mistaking papers for policy.
Read article →
United Kingdom psilocybin rescheduling debates post 2020
Since 2020, UK debate on psilocybin has intensified around Schedule 1 barriers, ACMD advice, and research friction. Here is what rescheduling talk means versus what law still requires.
Read article →
Czech Republic and psychedelic policy overview
The Czech Republic combines active scientific interest in psychedelics with conventional controlled-substance law. This overview separates research culture, political proposals, and what visitors can legally assume.
Read article →
Switzerland's compassionate use and psychedelic trials
Switzerland combines cautious medicines regulation with limited exceptional access and active academic trials. Here is how compassionate use, Swissmedic, and research protocols differ from open tourism.
Read article →
Germany's psychedelic research funding and pilot programs
Germany’s psychedelic momentum is concentrated in research funding, hospital ethics pathways, and regulator dialogue, not in retail tourism. Here is how BMBF, BfArM, and academic pilots actually fit together.
Read article →
Spain psilocybin retreats in legal gray zones: what is actually allowed
Spanish psilocybin retreat marketing often sits in a gray zone between private consumption claims, club narratives, and criminal supply law. Here is what is actually allowed versus advertised.
Read article →
Portugal drug decriminalization and psilocybin: myths vs law
Portugal’s 2001 reform decriminalized personal drug possession, but it did not legalize psilocybin sales or retreat tourism. Here is how the myths diverge from SICAD practice and criminal law.
Read article →
Cost of legal psilocybin retreats in Europe: transparent breakdown
A transparent breakdown of what legal European psilocybin retreat prices usually fund: venue, staffing, screening, food, integration, and travel margins.
Read article →
Ethics of facilitator training: ICPR, MAPS legacy, and European programs
What ethical facilitator training looks like in Europe: ICPR-era learning culture, MAPS legacy themes, consent, scope of practice, and questions to ask before you trust a title.
Read article →
Post retreat travel: why many stay an extra night before flying
Why many retreat guests book an extra night before flying home: sleep, emotion regulation, airport stress, and safer re-entry after an intense programme.
Read article →
Seasonal retreat planning in the Netherlands: weather, daylight, and comfort
Plan a Netherlands retreat by season: weather, daylight hours, indoor comfort, travel reliability, and how climate shapes set and setting.
Read article →
Accessibility at retreats: mobility, diet, and sensory needs
Plan accessibility before you book a retreat: mobility paths, dietary care, and sensory load. Questions that turn vague welcomes into concrete accommodations.
Read article →
Green flags in retreat operations: screening, medical support, integration
Operational green flags for psilocybin retreats: serious screening, clear medical support pathways, and integration that continues after you leave.
Read article →
Red flags in retreat marketing: medical claims, guarantees, and secrecy
How to spot risky retreat marketing: medical cure claims, outcome guarantees, and secrecy that blocks informed consent. A practical due diligence guide.
Read article →
Retreats for first timers vs experienced explorers: matching expectations
First-timers and experienced explorers need different pacing, dose ethics, and peer culture. A practical guide to matching retreat expectations without hierarchy games.
Read article →
Couples at psychedelic retreats: shared vs separate sessions
Shared or separate sessions change consent, attention, and attachment dynamics for couples at psychedelic retreats. A practical framework for choosing architecture.
Read article →
VIP and small group retreats: when extra privacy helps
VIP and small-group psilocybin retreats help when confidentiality and attention are real needs. Learn how to separate useful privacy from status packaging.
Read article →
3 day vs 5 day psilocybin programs: intensity, rest, and outcomes
Three-day and five-day psilocybin programmes differ in pacing, rest, travel stress, and integration realism. Choose length by logistics and recovery capacity, not mystique.
Read article →
Silent retreat vs conversational integration days: format comparison
Silence and conversation shape integration differently after psilocybin. A practical format comparison to match speech policy with your nervous system and goals.
Read article →
Group size and facilitator ratios: what research and standards suggest
How group size and facilitator ratios shape safety and attention at psilocybin retreats, translated from clinical research habits into practical booking questions.
Read article →
What happens on day 1 of a psilocybin retreat: a neutral walkthrough
A calm, practical walkthrough of day 1 at a psilocybin retreat: arrival, agreements, intention, rest, and whether dosing happens yet. Neutral guidance for realistic expectations.
Read article →
Returning to work after a psilocybin retreat: disclosure and boundaries
How to return to work after a psilocybin retreat: optional disclosure ladders, workplace boundaries, energy management, and when to prioritise clinical care over attendance optics.
Read article →
Integration timelines: week 1, month 1, month 3, year 1
A practical post-psilocybin integration timeline: stabilise in week 1, build habits in month 1, stress-test at month 3, and review character at year 1 without rigid promises.
Read article →
Peer communities after retreats: role of alumni groups in long term support
How alumni groups and peer communities support post-retreat integration: green and red flags, online versus in person, and building a support stack when no programme exists.
Read article →
When insights fade: normalizing the integration plateau
Why post-retreat insights often fade, how the integration plateau is part of learning, myths that worsen it, and what to practice when awe thins without chasing another peak.
Read article →
Micro habits that anchor insights: behavior design for lasting change
Turn post-retreat insights into lasting change with tiny, cue-based habits: behaviour design, friction reduction, gentle rewards, and a four-week starter plan without productivity theatre.
Read article →
Pre retreat reading list: books and papers worth your time
A short pre-retreat reading list of books and papers can steady expectations without becoming intellectual armour. Choose little, rest more.
Read article →
Timing your retreat around work and childcare: practical planning
Timing a psilocybin retreat around work and childcare means real coverage plans, recovery buffers, and handoffs finished before you travel.
Read article →
Pre retreat health questionnaire: why retreats ask about medications and history
Pre-retreat health questionnaires exist so teams learn medication and history risks before the session, not during it. Here is how to answer with care.
Read article →
Language and multilingual retreats: how to prepare if sessions are not in your native tongue
When a retreat runs outside your native language, prepare safety phrases, consent clarity, and cognitive spare capacity rather than chasing perfect fluency.
Read article →
Fitness and psilocybin: physical preparation myths and facts
Fitness myths before a psilocybin retreat rarely match real preparation: stability, screening honesty, and comfort in stillness matter more than crash training.
Read article →
Integration and addiction recovery: what peer support programs teach
Peer support traditions in addiction recovery offer durable lessons for psychedelic integration: honesty, sponsorship-like accountability, meeting rhythms, and one-day-at-a-time behaviour change without treating a session as a cure.
Read article →
Spiritual bypassing after psychedelics: how to stay grounded
Psychedelic insight can deepen wisdom or become a way to skip grief, conflict, and responsibility. A grounded guide to spotting spiritual bypassing after psilocybin and returning to ordinary life with integrity.
Read article →
Managing pre retreat anxiety: evidence based tools without self medicating
Pre-retreat nerves are common. Here are evidence-aligned tools for anxiety before a psilocybin retreat, plus clear reasons to avoid self-medicating with alcohol, extras, or improvised sedatives.
Read article →
Retreat packing beyond the basics: eye mask, journal, layers, and comfort items
A packing list for psilocybin retreats that goes past toothpaste and chargers: eye masks, journals, layers, and comfort items that protect sensory calm without turning your bag into a pharmacy.
Read article →
Difficult experiences and integration: processing fear, grief, or confusion
A hard psilocybin session is not a failed session. This guide offers grounded ways to process fear, grief, and confusion in the days and weeks that follow, and clear signals for when to get extra help.
Read article →
Sleep hygiene after psilocybin: restoring rhythm in the first week
Psilocybin can scramble sleep for several nights. This guide explains why rhythm breaks, what to do on days 0 to 7, and which habits restore restorative sleep without forcing it.
Read article →
Solo travel to a Netherlands retreat: trains, eSIM, cash, and accessibility
Arriving alone for a Netherlands psilocybin retreat is straightforward if you plan trains, connectivity, payments, and accessibility early. A practical field guide for solo travellers.
Read article →
What to tell your partner or family before you go: honest communication guide
Leaving for a psilocybin retreat raises hard questions at home. This guide covers what partners and family actually need to know before you go, how much detail helps, and how to set agreements for the return.
Read article →
Nature walks as integration: how time outdoors supports post-psilocybin processing
Walking in nature after a psilocybin retreat is not just pleasant. Research on forest bathing, nature connectedness, and nervous system regulation suggests it may be one of the most accessible and effective integration practices available.
Read article →
Creative integration: how art, music, and movement help process psilocybin experiences
Words alone cannot capture the full texture of a psilocybin experience. Art, music, and movement offer parallel channels for processing, allowing material that resists verbal expression to find form, release, and meaning.
Read article →
Digital detox before a retreat: why unplugging early supports the process
Constant screen time keeps the nervous system in a state of low-grade vigilance that undermines retreat readiness. Starting a digital detox days before your session reduces mental noise, restores attention, and primes the brain for introspection.
Read article →
Meditation before psilocybin: does a personal practice change the experience?
Research suggests that meditators may navigate psilocybin sessions differently, but even a few weeks of practice can meaningfully shift your capacity for surrender and presence.
Read article →
Integration and relationships: talking to loved ones about your experience
Sharing a psychedelic experience with partners, family, or friends requires timing, framing, and emotional intelligence. This guide covers when to share, what to share, and how to protect both yourself and your relationships.
Read article →
When to seek a therapist after psychedelics: green flags and red flags
Not everyone needs therapy after a psilocybin retreat, but some people do. This guide distinguishes normal post-session adjustment from warning signs that warrant professional support.
Read article →
Intention setting that actually helps: frameworks from integration research
Many retreat participants set intentions that are too vague or too rigid. This guide draws on integration research to build intention frameworks that genuinely support the psychedelic process.
Read article →
Benzodiazepines and psychedelics: anxiety management before a retreat
Benzodiazepines can blunt or block psilocybin effects. This guide covers pharmacology, tapering timelines, and safer anxiety management strategies for retreat preparation.
Read article →
Journaling prompts for the first 30 days after psilocybin
The first month after psilocybin is a sensitive integration window. These structured journaling prompts help translate insights into behavior, boundaries, and stable emotional regulation.
Read article →
Integration circles vs solo practice: benefits and limits of each
Should post-retreat integration happen in groups or alone? This practical guide compares integration circles and solo work across safety, depth, accountability, and long-term behavior change.
Read article →
SSRI and psilocybin: why tapering decisions belong with your doctor
Many retreat participants ask whether they should stop SSRIs before psilocybin. This guide explains why tapering must be clinician-led, what risks matter, and how to plan responsibly without self-directed withdrawal.
Read article →
MAOI foods and psilocybin: tyramine, interactions, and retreat meal planning
Confusion around MAOI food rules is common in psychedelic preparation. This evidence-based guide explains tyramine risk, what applies to psilocybin retreats, and how to build a simple pre-retreat meal plan.
Read article →
Integration defined: why the days after matter as much as the session
Integration is the disciplined process of translating psychedelic experiences into durable life changes. This guide explains what integration is, what it is not, and how to structure the first months after retreat.
Read article →
Pre retreat diet: why many facilitators recommend light, simple food
A practical, evidence-aware guide to pre-retreat eating: what light and simple meals can support, what they cannot do, and how to adapt plans safely to your health needs.
Read article →
Exporting truffles from the Netherlands: what the law says for tourists
Buying magic truffles in Amsterdam feels straightforward until you pack for the flight home. Dutch tolerance policy governs retail inside the Netherlands. It does not grant travelers a passport to carry psilocybin...
Read article →
Psilocybin retreats are not therapy
Why legal psilocybin retreats in the Netherlands are not psychotherapy, and how to interpret marketing claims responsibly.
Read article →
Tolerance to psilocybin: why redosing rarely works and how long to wait
Psilocybin produces profound effects at moderate doses, which leads some participants to wonder whether taking more during the same afternoon will extend or intensify the journey. In most cases redosing fails....
Read article →
Cross tolerance between psilocybin and other classic psychedelics
Cross tolerance means using one serotonergic psychedelic reduces responsiveness to another within a short window because they share primary receptor targets. Psilocybin, LSD, mescaline, and DMT all engage 5 HT2A...
Read article →
Are magic truffles vegan, organic, and allergen free: a factual checklist
Retreat menus and smart shop shelves increasingly carry vegan, organic, and allergen-free language beside magic truffle strain names. Fungi themselves are not animal products, yet substrate grains, processing lines,...
Read article →
Patient selection in psilocybin trials: exclusions and rationale
Why psilocybin trials exclude many real-world patients, how criteria protect safety, and what generalizability limits mean.
Read article →
Lookalike mushrooms and poisoning risk: why foraging is dangerous
Fatal mushroom poisonings rarely involve psilocybin itself. They involve amatoxins and other lethal compounds in species that resemble liberty caps or wood loving Psilocybe on casual inspection. Foraging forums...
Read article →
Neuroplasticity after psilocybin: BDNF, synaptogenesis, and what we know in 2026
Neuroplasticity describes the brain's capacity to reorganize synaptic connections in response to experience, injury, or pharmacological signals. Psilocybin research revived interest in whether a single supervised...
Read article →
Panic during psilocybin: breathing, reassurance, and environment changes
Panic during psilocybin. Educational guide on risk, screening, and harm reduction for psilocybin contexts.
Read article →
Psilocybin and eating disorders: why research is still preliminary
Hopkins and Imperial College pilot psilocybin for anorexia and related disorders under strict medical monitoring. Why evidence remains early stage and retreats are risky.
Read article →
Psilocybin metabolites in blood and urine: what toxicology screens detect
Toxicology laboratories detect psilocybin exposure by targeting psilocin and its glucuronide conjugates in blood and urine rather than the parent phosphate ester, which disappears quickly after oral ingestion....
Read article →
Psilocybin and OCD: early trials and open questions
Moreno 2006 pilot and Yale ongoing trials explore psilocybin assisted therapy for obsessive compulsive disorder. Early evidence, mechanisms, and caution explained.
Read article →
Alcohol before or after psilocybin: harm reduction perspective
Alcohol before or after psilocybin. Educational guide on risk, screening, and harm reduction for psilocybin contexts.
Read article →
How to read truffle packaging labels: strain names and strength indicators
Dutch truffle pouches pack legal, tax, and pharmacological information into a few square centimeters of label space. Strain fantasy names, fresh gram weights, best before dates, and strength tiers each answer...
Read article →
Psilocybe species overview: which mushrooms contain psilocybin
The genus Psilocybe groups more than a hundred described species, yet only a handful appear on Dutch shop labels, cultivation forums, or clinical trial paperwork. Names like Mexicana, Tampanensis, and Atlantis are...
Read article →
Psychedelic first aid training: what RET and similar programs teach
Psychedelic first aid training. Educational guide on risk, screening, and harm reduction for psilocybin contexts.
Read article →
End of life anxiety and psilocybin: ethics, outcomes, and access
How clinical psilocybin research addresses existential distress in serious illness, and why ethics and access remain central.
Read article →
Opium Act and psilocybin truffles: the legal text in plain English
The Dutch Opium Act (Opiumwet) is the primary statute governing controlled substances in the Netherlands. For international visitors researching psilocybin retreats, the most practical question is how the written law...
Read article →
HPPD and psilocybin: prevalence, symptoms, and what the literature says
Hallucinogen persisting perception disorder, abbreviated HPPD, describes visual disturbances such as trails, halos, or static that continue after the acute psychedelic effects have ended. Case reports exist across...
Read article →
From Hofmann to today: milestones in psilocybin research timeline
Modern psilocybin headlines compress seven decades into a single breakthrough narrative, yet the research timeline includes prohibition eras, dormant decades, and renewed multicenter trials with distinct...
Read article →
Tramadol, opioids, and psilocybin: serotonin syndrome awareness
Tramadol, opioids, and psilocybin. Educational guide on risk, screening, and harm reduction for psilocybin contexts.
Read article →
FDA breakthrough therapy and psilocybin: current status
What FDA Breakthrough Therapy designation means for psilocybin developers, patients, and how it differs from state service laws.
Read article →
Liability and waivers at legal retreats: what participants should understand
Psilocybin retreat contracts in the Netherlands often arrive as PDF waivers attached to booking emails. Participants click accept to secure a ceremony date without reading assumption of risk clauses, liability caps,...
Read article →
Police encounters and psilocybin in the Netherlands: what statistics show
Headlines about Dutch drug tolerance rarely cite police statistics, yet numbers matter when you assess how often psilocybin actually appears in enforcement data. Official crime tables, hospital presentations, and...
Read article →
Truffle grading and quality control in legal Dutch supply chains
Legal magic truffles in the Netherlands pass through a supply chain that looks informal from a tourist sidewalk yet runs on repeatable cultivation, packaging, and retail habits. Grading is not a government...
Read article →
Absolute contraindications for psilocybin: psychiatric and medical list
Absolute contraindications for psilocybin. Educational guide on risk, screening, and harm reduction for psilocybin contexts.
Read article →
Set and setting: the science behind context and psychedelic outcomes
Set and setting entered psychedelic vocabulary in the mid twentieth century when clinicians noticed identical milligram doses produced radically different outcomes depending on mood, expectations, and physical...
Read article →
Fresh vs dried magic truffles: potency, weight, and storage science
Fresh magic truffles are mostly water. That single fact drives dosing confusion, shipping logistics, and every argument about whether drying increases power. This article explains moisture math, how alkaloids...
Read article →
Imperial College London psilocybin research: key findings explained
Imperial College London hosts one of the world's leading psychedelic research centres. Its trials combine brain imaging with psychotherapy to study psilocybin for depression and related conditions.
Read article →
Difficult trips: sitter roles, grounding techniques, and when to call medical help
Difficult trips. Educational guide on risk, screening, and harm reduction for psilocybin contexts.
Read article →
Psilocybin vs MDMA vs ketamine: different tools, different mechanisms
Media coverage often lumps psychedelic therapy into a single headline, yet psilocybin, MDMA, and ketamine engage different receptor systems, produce different subjective profiles, and follow different regulatory...
Read article →
Future of Dutch psychedelic policy: decriminalization debates in 2026
Dutch psychedelic policy headlines in 2026 oscillate between codifying truffle tolerance, tightening tourism enforcement, and expanding hospital research access. Parliamentary debates attract international attention...
Read article →
Psilocybin for tobacco cessation: Matthew Johnson research in plain language
Matthew Johnson at Johns Hopkins published influential psilocybin smoking cessation trials with high verified abstinence rates. This article explains methods, follow up, and limits.
Read article →
Johns Hopkins psilocybin studies: what changed between 2006 and today
Johns Hopkins University reopened modern psilocybin science in 2006 and now runs one of the world's largest clinical programs. This timeline explains landmark studies and what they mean for mental health research.
Read article →
Pregnancy, breastfeeding, and psilocybin: absence of safety data
Pregnancy, breastfeeding, and psilocybin. Educational guide on risk, screening, and harm reduction for psilocybin contexts.
Read article →
Truffles and the 2008 Dutch mushroom ban: why sclerotia remained legal
In December 2008 the Netherlands criminalized fresh psilocybin mushrooms while leaving psilocybin-containing sclerotia on the commercial market. Parliament did not publish a pharmacology finding that truffles are...
Read article →
How magic truffles are cultivated in the Netherlands: process without promotion
Licensed Dutch growers supply most of the psilocybin sclerotia sold legally in Europe. Their workflow looks more like controlled food fermentation than a kitchen grow kit: sterile grain, incubation halls, batch...
Read article →
Psilocybin and the gut: emerging research on the microbiome connection
Interest in gut brain signaling has expanded from irritable bowel psychiatry clinics into psychedelic pharmacology as researchers ask whether serotonin active compounds reshape microbial communities or whether...
Read article →
Schengen rules and psychedelic tourism: staying compliant as a visitor
Psychedelic tourism to the Netherlands often begins with questions about truffles and ends with questions about passports. Schengen compliance governs how long you may remain in Europe, how entry and exit are...
Read article →
Survey data on self reported mental health changes after retreats
How post-retreat surveys are collected, why selection bias limits inference, and what they cannot prove about clinical efficacy.
Read article →
Psilocybin mushrooms vs truffles: bioavailability and onset time differences
Travelers often ask whether magic mushrooms and magic truffles feel different because of chemistry or because of how products are sold in Amsterdam. Both forms deliver psilocybin, which converts to psilocin in the...
Read article →
Schizophrenia spectrum and psychedelics: why caution is standard
Schizophrenia spectrum and psychedelics. Educational guide on risk, screening, and harm reduction for psilocybin contexts.
Read article →
What is psilocybin: chemical structure, natural sources, and how the body converts it
Psilocybin occupies a distinctive place in pharmacology as a naturally occurring tryptamine alkaloid produced by more than two hundred species of fungi, including Psilocybe mushrooms and the sclerotia sold legally as...
Read article →
Cannabis plus psilocybin: intensification risks at retreats
Cannabis plus psilocybin. Educational guide on risk, screening, and harm reduction for psilocybin contexts.
Read article →
Medical cannabis vs psilocybin truffles in Dutch law: side by side
The Netherlands hosts two radically different legal regimes for psychoactive plants that international visitors often conflate. Medical cannabis moves through pharmacy channels with prescriber oversight, Ministry of...
Read article →
Psilocybin and anxiety in life threatening illness: Grob and Ross studies
Grob 2011 and Ross 2016 NYU Langone trials tested psilocybin assisted therapy for cancer related anxiety and existential distress. This article summarizes outcomes, limits, and how clinical research differs from retreats.
Read article →
Insurance and psilocybin retreats: what travel policies typically exclude
Travel insurance policies sold to tourists rarely cover psilocybin retreat incidents the way brochures imply. Standard wordings exclude unlawful acts, voluntary intoxication, undisclosed hazardous activities, and...
Read article →
Psilocybin content by strain: Tampanensis, Mexicana, Atlantis, and what labels mean
Shop menus list Tampanensis, Mexicana, Atlantis, and a parade of fantasy names implying predictable psilocybin milligrams. Laboratory reality is messier: overlapping ranges, moisture dependence, and scarce peer...
Read article →
Psilocybin purity and adulterants: risks in unregulated markets vs legal truffles
Unregulated psychedelic markets sell dried mushrooms, powders, and tablets whose active ingredient identity is often unknown without laboratory testing. Legal Dutch sclerotia supply chains operate under different...
Read article →
Adverse events in clinical psilocybin trials
How sponsors report adverse events in psilocybin trials, what serious events look like, and how denominators shape public understanding of risk.
Read article →
Environmental conditions for sclerotia formation: temperature, humidity, substrate
Sclerotia are not accidental lumps in a grow tray. They form when psilocybin-producing fungi interpret environmental stress as a signal to store nutrients underground rather than invest in mushroom caps. Indoor Dutch...
Read article →
Smart shops vs retreats: legal differences and consumer protection
Smart shops and psilocybin retreats both operate inside Dutch tolerance culture, yet they answer to different legal frameworks, consumer rules, and complaint channels. A counter purchase is a product sale with short...
Read article →
Group safety at retreats: ratios, screening, and emergency protocols
Group safety at retreats. Educational guide on risk, screening, and harm reduction for psilocybin contexts.
Read article →
Heart conditions and psilocybin: blood pressure and arrhythmia considerations
Heart conditions and psilocybin. Educational guide on risk, screening, and harm reduction for psilocybin contexts.
Read article →
Therapeutic windows: why session length matters in clinical trials
Clinical teams speak about therapeutic windows when describing how long a psilocybin session remains pharmacologically active and psychologically workable before effects taper into integration. Trial protocols fix...
Read article →
Driving and cycling after psilocybin in the Netherlands: legal and safety limits
Operating a car or bicycle after psilocybin at a Netherlands retreat raises questions that truffle tolerance alone cannot answer. Dutch road law targets incapacity behind the wheel, not whether purchase was lawful on...
Read article →
Psilocybin and sleep: what happens to sleep architecture after a session
Sleep complaints after psychedelic sessions are common in retreat surveys yet rarely measured with the same rigor as mood scales in depression trials. Polysomnography, the gold standard for sleep architecture,...
Read article →
EMA and European psilocybin medicine pathways
How EMA centralized procedures, national implementation, and HTA shape potential European psilocybin medicine access.
Read article →
Truffle shelf life: signs of spoilage and when not to consume
Fresh magic truffles are perishable biological material, not shelf-stable supplements. From the moment a grower harvests sclerotia until you open a vacuum bag, clock starts on moisture loss, enzymatic change, and...
Read article →
Lithium and psychedelics: a documented dangerous interaction
Lithium and psychedelics. Educational guide on risk, screening, and harm reduction for psilocybin contexts.
Read article →
Bringing prescription medication to a Netherlands retreat: customs and documentation
Travelers heading to a psilocybin truffle retreat in the Netherlands routinely pack passports, comfortable clothes, and journals. Far fewer prepare how prescription medicines interact with customs, airline security,...
Read article →
Psilocin explained: the active molecule behind psilocybin effects
Psilocin is the pharmacologically active metabolite formed when alkaline phosphatases cleave the phosphate group from psilocybin. Unlike the prodrug, psilocin bears a free hydroxyl at the four position of the indole...
Read article →
Identifying psilocybin mushrooms in the wild: safety warnings and legal risks
Autumn meadows and wood chip beds tempt visitors to pick wild psilocybin mushrooms after reading species lists online. The activity combines botanical difficulty, criminal risk, and occasional fatal poisoning when...
Read article →
Mycelium vs sclerotium: the life cycle of psilocybin producing fungi
Psilocybin fungi express multiple body plans during one life cycle: microscopic spores, threadlike mycelium, above ground mushrooms, and underground sclerotia. Dutch law cares about which form sits on a shop shelf;...
Read article →
Psilocybin for alcohol use disorder: NYU and related trials
Michael Bogenschutz led NYU trials including a 2022 JAMA Psychiatry randomized study of psilocybin assisted therapy for alcohol use disorder. Design, outcomes, and limits explained.
Read article →
Can you fly home after a truffle retreat: airport, customs, and personal risk
Flying home after a psilocybin truffle retreat in the Netherlands is legally unlike the day you consumed truffles on Dutch soil. Airport security, airline conditions of carriage, export controls, and the import law...
Read article →
Psilocybin and serotonin receptors: why the 5 HT2A receptor matters
Classic psychedelics including psilocybin produce their characteristic effects primarily through agonism at the serotonin 5-HT2A receptor, a G protein-coupled receptor enriched on cortical pyramidal neurons....
Read article →
Psychedelic assisted therapy vs retreat model: structural differences
Clinical psychedelic-assisted therapy and group retreats share psilocybin but diverge sharply in regulation, staffing, and therapeutic intent.
Read article →
Amsterdam vs rural retreat venues: legal and practical comparison
Choosing between an Amsterdam area retreat and a rural Netherlands venue is not a choice between legal and illegal. The Opium Act applies nationwide, and truffle tolerance follows national administrative practice...
Read article →
Psilocybin for treatment resistant depression: COMPASS Pathways and beyond
Treatment resistant depression affects millions who fail two or more antidepressant courses. COMPASS Pathways COMP360 trials and academic studies are testing whether psilocybin with psychological support can offer a new path.
Read article →
Sexual boundaries during psychedelic experiences: consent and facilitation ethics
Sexual boundaries during psychedelic experiences. Educational guide on risk, screening, and harm reduction for psilocybin contexts.
Read article →
Sun exposure and psilocybin outdoors: heat, perception, and safety
Sun exposure and psilocybin outdoors. Educational guide on risk, screening, and harm reduction for psilocybin contexts.
Read article →
Historical use of teonanacatl and sclerotia in Mesoamerican cultures
Teonanacatl is a Nahuatl term often translated as flesh of the gods. Spanish chroniclers and twentieth century ethnomycologists used it when describing psychoactive mushrooms in Mesoamerican ritual life. Modern Dutch...
Read article →
Workplace drug testing in the Netherlands and psilocybin metabolites
Workplace drug testing in the Netherlands intersects awkwardly with truffle tolerance. Domestic law may tolerate personal psilocybin use in private settings, yet employers, especially multinationals, can still screen...
Read article →
Default mode network and psilocybin: what brain imaging studies show
Functional brain imaging changed how researchers talk about psilocybin. Instead of treating psychedelic states as opaque subjective events, teams at Imperial College London, Johns Hopkins, and collaborating...
Read article →
Hydration and fasting: avoiding dehydration without over drinking
Hydration and fasting. Educational guide on risk, screening, and harm reduction for psilocybin contexts.
Read article →
Psilocybin and PTSD: comparison with MDMA assisted therapy
MAPS Mitchell 2022 NEJM trial advanced MDMA assisted therapy for PTSD while psilocybin PTSD research remains earlier stage. Evidence, protocols, and safety compared.
Read article →
Synthetic psilocybin vs natural truffles: clinical and experiential differences
Hospital depression trials increasingly administer synthetic psilocybin capsules while Dutch smart shops sell psilocybin inside wet fungal sclerotia. Both routes deliver the same prodrug eventually converted to...
Read article →
Bipolar disorder and psilocybin: mania risk and professional guidance
Bipolar disorder and psilocybin. Educational guide on risk, screening, and harm reduction for psilocybin contexts.
Read article →
Placebo, expectancy, and blinding in psilocybin trials
Why double-blind designs struggle with psilocybin, how expectancy shapes outcomes, and what readers should infer from trial statistics.
Read article →
Psilocybin vs LSD vs mescaline: pharmacology comparison for curious readers
Classic psychedelics share a family resemblance: altered perception, time distortion, and introspective depth after serotonergic receptor activation. Psilocybin, LSD, and mescaline nevertheless differ in chemistry,...
Read article →
Age limits for truffle purchase and retreat participation in the Netherlands
Buying magic truffles at a Dutch smart shop and joining a psilocybin retreat are both legal conversations for adults, yet age rules differ between retail counters and ceremony contracts. Shops routinely enforce...
Read article →
How long does psilocybin stay in your system: metabolism, half life, and detection windows
Psilocybin itself is largely absent from blood within hours because alkaline phosphatases rapidly convert it to psilocin, the analyte that best reflects acute exposure. Half-life estimates for psilocin center near...
Read article →
Sclerotia explained: why truffles are not botanical truffles
Walk into a Dutch smart shop and you will see products labeled magic truffles. The word truffle evokes black Perigord fungi scraped from oak roots, yet what you are buying is something else entirely: a sclerotium, a...
Read article →
Psilocybin and the Hypnagogic Lamp: Synergies for Expanded States of Consciousness
Psilocybin and the hypnagogic lamp represent two powerful gateways into altered states of consciousness. One works through chemistry on serotonin receptors, the other through rhythmic light stimulation. When they meet, or when used in a complementary way, they open fascinating possibilities for deep...
Read article →
Journaling, Therapy, and Daily Practices: How to Turn a Psychedelic Experience into Lasting Change
A psychedelic experience, especially one that takes place in the safe and supportive setting of a retreat, can be profoundly impactful. Many participants return with a deep sense of clarity, emotional openness, or a fresh understanding of their life. Yet without conscious integration work, these pow...
Read article →
Complete Checklist: What to Pack in Your Suitcase for a Psilocybin Retreat in the Netherlands?
Preparing your suitcase for a psilocybin retreat in the Netherlands requires a careful balance between practicality, comfort, and intention. The Dutch climate, the length of the stay, the safety rules of the retreat, and the integration work all call for a thoughtful list. At retraite-eveil.com, we...
Read article →
Psychedelic Retreats in Europe: Why the Netherlands Is the Safest and Most Accessible Destination
Psychedelic retreats are attracting more and more people across Europe who are looking for a legal, safe, and professional setting to explore psilocybin responsibly. Among all possible destinations on the continent, the Netherlands clearly stands out as the safest and most accessible choice. Thanks...
Read article →
Richard Ohebshalom: From Eastern Wisdom and the Phoenix Rebirth to Founder of Foundation
Richard Ohebshalom is a powerful example of how spiritual exploration, inner transformation, and daily choice of resilience can fuel exceptional business success and a lasting vision. As the founder of Foundation, the private platform for real estate and heritage advisory spanning New York, Israel,...
Read article →
Seasonality: Why Do a Psychedelic Retreat in Spring or Summer?
Nature follows precise cycles, and our body and mind naturally align with them. In spring, everything is reborn. In summer, energy reaches its peak. These two seasons offer a particularly favorable environment for a psychedelic retreat. At retraite-eveil.com, we notice that many participants conscio...
Read article →
Are Psychedelic Retreats Right for Me? The 10 Signs to Look For
More and more people are asking themselves the same question: is a psychedelic retreat right for me? Between curiosity, hope for healing, and legitimate apprehension, it is completely normal to hesitate. Psychedelic retreats with psilocybin or other sacred plants are not a miracle solution, but they...
Read article →
Valeriia Akatova: From Kyiv Under Fire to Guide at Retraite Eveil and Co-Founder of Foundation Ukraine
Valeriia Akatova is a living example of resilience and transformation. Born in January 1993 in Ukraine, she lived through the horror of war in Kyiv in February 2022, fled with her seven-year-old daughter, rebuilt her life in France, and today serves as co-founder and Chief Operating Officer of Found...
Read article →
What the Trump Order to Allow Research on Psychedelic Drugs for Medical Purposes Means for Psychedelic Aficionados
On April 18, 2026, President Donald Trump signed an executive order titled “Accelerating Medical Treatments for Serious Mental Illness.” This directive instructs federal agencies to fast-track research and review processes for certain psychedelic compounds, with a particular focus on their potential...
Read article →
Psychedelic Retreats and Personal Development: When Traditional Medicine Meets Modern Science!
Psychedelic retreats have seen remarkable growth in recent years. More and more people are turning to these guided experiences as a path to personal development, emotional healing, and deeper self-understanding. What makes these retreats particularly compelling is that they create a bridge between t...
Read article →
Food, meditation, and intentions: how to maximize the benefits of a psilocybin immersion
Most people focus only on dosage-but food, meditation, and intentions actually determine your psilocybin journey's depth. Learn how to prepare.
Read article →
Psychedelic Retreats: How They Help You Let Go of Control and Regain Clarity
In a world where control often seems to be the key to success, many people experience deep exhaustion from the constant effort of trying to manage everything. Work, relationships, emotions, projects, everything must be planned, anticipated, and mastered. This permanent quest for control can lead to...
Read article →
The Legislation of Magic Truffles in the Netherlands: Everything You Need to Know
Magic truffles, also known as psilocybin sclerotia, occupy a unique place in the European legal landscape. In the Netherlands, they remain perfectly legal for cultivation, sale, and personal consumption, while magic mushrooms (the above-ground parts) have been banned since 2008. This distinction fas...
Read article →
The 7 Most Common Mistakes Before a Psilocybin Experience
Preparing for an experience with magic truffles or magic mushrooms requires care and reflection. Many people approach this journey with enthusiasm, but without adequate preparation, the risk of an uncomfortable or less enriching experience increases. On retraite-eveil.com, we emphasize an educationa...
Read article →
Visuals vs Insights: What People Experience Most Often
When people talk about a psilocybin journey with magic truffles or magic mushrooms, many immediately imagine spectacular visual hallucinations: vivid colors, geometric patterns, and dancing shapes. Yet the real experiences reported by thousands of participants and confirmed by scientific studies sho...
Read article →
The Phases of a Psilocybin Journey: Come-Up, Plateau, and Descent
A psilocybin journey, whether with magic truffles or magic mushrooms, generally follows a predictable progression through three main phases: the come-up, the plateau, and the descent. Knowing these stages helps you prepare better, navigate with calm, and get the most benefit for personal growth and...
Read article →
Studies and Testimonials: How Psilocybin Helps Combat Depression?
Depression affects millions of people around the world and represents one of the most significant challenges in mental health today. Despite advances in conventional treatments, many individuals do not find lasting relief with traditional antidepressants or standard therapies. It is in this context...
Read article →
Unusual bodily sensations: understanding and welcoming them
When people take magic truffles or magic mushrooms, they often notice changes not just in their thoughts or vision but also in their bodies. These unusual bodily sensations can feel surprising at first. Yet they form a natural part of the psilocybin experience and carry real value when approached wi...
Read article →
How to Store Magic Truffles: Fresh, Dried & Long-Term Guide
Magic truffles, also known as Psilocybe sclerotia, are underground formations produced by certain hallucinogenic mushrooms. Unlike traditional magic mushrooms that grow above ground, these truffles are compact masses of mycelium that serve as nutrient reserves for the mushroom during adverse environ...
Read article →
Psilocybin vs. Psilocine : Differences, effects, conversion, dosage, research, and safety
Hallucinogenic mushrooms (also known as psilocybin mushrooms, shrooms , or psilocybe mushrooms) have been used for centuries for spiritual, therapeutic, and recreational purposes. Their potent psychedelic effects come from two closely related compounds: psilocybin and psilocin . Although these terms...
Read article →
The Difference Between Magic Mushrooms and Magic Truffles: A Complete Guide
Discover why magic truffles are the ideal option for your legal psychedelic retreat in the Netherlands.In a world dominated by stress, anxiety, and the search for meaning, more and more people are turning to natural psychedelics for profound transformation. At Retraite Eveil, we organize guided psyc...
Read article →
How to Prepare for a Peaceful Trip on Psychedelics
Psychedelics such as psilocybin, LSD, mescaline, or DMT can offer profound experiences that transform your perception of self and the world. However, to avoid unpleasant surprises and maximize the benefits, careful preparation is essential. In this in-depth guide, we explore how to prepare for a ser...
Read article →
How to consume magic mushrooms safely?
Legal Context and Safety Considerations In the Netherlands, psilocybin is legally available in the form of magic truffles. Before engaging in any personal exploration, it is essential to inform yourself about and comply with the laws in your country of residence. Questions about safety are common wh...
Read article →
Psilocybin Dosage Guidelines for Magic Truffles
Psilocybin, the active compound in magic truffles (sclerotia of certain psilocybin-containing fungi), can produce a range of psychological effects depending on the dose. Determining an appropriate dosage is highly individual and influenced by factors such as body weight, personal sensitivity, prior...
Read article →